346 related articles for article (PubMed ID: 22253723)
1. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
[TBL] [Abstract][Full Text] [Related]
3. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
[TBL] [Abstract][Full Text] [Related]
4. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
[TBL] [Abstract][Full Text] [Related]
5. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
[TBL] [Abstract][Full Text] [Related]
6. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
Garg N; Singh R; Shukla G; Capalash N; Sharma P
Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
[TBL] [Abstract][Full Text] [Related]
7. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.
Huang W; Yao Y; Long Q; Yang X; Sun W; Liu C; Jin X; Li Y; Chu X; Chen B; Ma Y
PLoS One; 2014; 9(6):e100727. PubMed ID: 24956279
[TBL] [Abstract][Full Text] [Related]
8. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
Singh R; Capalash N; Sharma P
Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
[TBL] [Abstract][Full Text] [Related]
9. The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.
Wang-Lin SX; Olson R; Beanan JM; MacDonald U; Balthasar JP; Russo TA
Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28947651
[No Abstract] [Full Text] [Related]
10. The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.
Uppuluri P; Lin L; Alqarihi A; Luo G; Youssef EG; Alkhazraji S; Yount NY; Ibrahim BA; Bolaris MA; Edwards JE; Swidergall M; Filler SG; Yeaman MR; Ibrahim AS
PLoS Pathog; 2018 May; 14(5):e1007056. PubMed ID: 29746596
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
[TBL] [Abstract][Full Text] [Related]
12. Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection.
Aghajani Z; Rasooli I; Mousavi Gargari SL
APMIS; 2019 Dec; 127(12):753-763. PubMed ID: 31512768
[TBL] [Abstract][Full Text] [Related]
13. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.
McConnell MJ; Pachón J
Vaccine; 2010 Dec; 29(1):1-5. PubMed ID: 21044668
[TBL] [Abstract][Full Text] [Related]
14. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
Badmasti F; Ajdary S; Bouzari S; Fooladi AA; Shahcheraghi F; Siadat SD
Mol Immunol; 2015 Oct; 67(2 Pt B):552-8. PubMed ID: 26277277
[TBL] [Abstract][Full Text] [Related]
15. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii.
Bolourchi N; Shahcheraghi F; Shirazi AS; Janani A; Bahrami F; Badmasti F
Microb Pathog; 2019 Jun; 131():9-14. PubMed ID: 30930220
[TBL] [Abstract][Full Text] [Related]
17. Vesicle-Mediated Dendritic Cell Activation in
Cai W; Kesavan DK; Cheng J; Vasudevan A; Wang H; Wan J; Abdelaziz MH; Su Z; Wang S; Xu H
J Immunol Res; 2019; 2019():2835256. PubMed ID: 32083139
[No Abstract] [Full Text] [Related]
18. Development of Different Methods for Preparing
Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
Front Immunol; 2020; 11():1069. PubMed ID: 32655550
[No Abstract] [Full Text] [Related]
19. Cross-reactivity and immunotherapeutic potential of BamA recombinant protein from Acinetobacter baumannii.
Vieira de Araujo AE; Conde LV; da Silva Junior HC; de Almeida Machado L; Lara FA; Chapeaurouge A; Pauer H; Pires Hardoim CC; Martha Antunes LC; D'Alincourt Carvalho-Assef AP; Moreno Senna JP
Microbes Infect; 2021; 23(4-5):104801. PubMed ID: 33582283
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP
Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
